Arielle Rothstein

Arielle Rothstein

Managing Director at Joele Frank

Arielle Rothstein
By December 21, 2020 11:46 AM

When Arielle Rothstein arrived at Joele Frank in 2013, she was a 22-year-old account executive fresh out of college. In only five years, she’d become the firm’s youngest managing director to oversee multibillion-dollar mergers, shareholder activism campaigns and C-suite shakeups. 

“We help our clients ‘take control,’” said Joele Frank’s president, Matthew Sherman. And Rothstein’s “exceptional judgment and calm-under-fire attitude” achieve just that. In 2020, she advised clients on some of the most high-profile corporate events of the year, including COVID-19 drug Remdesivir maker Gilead Sciences’ $21 billion acquisition of Immunomedics and the appointment of McDonald’s new CEO. 

In her earlier years as managing director, Rothstein was also involved in Broadcom’s historic $130 billion proposed hostile takeover of Qualcomm (20172018) and subsequent M&A transactions. 

More articles about Joele Frank, remdesivir

We noticed you're using an ad blocker.

We get it: you like to have control of your own internet experience.
But advertising revenue helps support our journalism.

To read our full stories, please turn off your ad blocker.
We'd really appreciate it.

How Do I Whitelist Observer?

How Do I Whitelist Observer?

Below are steps you can take in order to whitelist on your browser:

For Adblock:

Click the AdBlock button on your browser and select Don't run on pages on this domain.

For Adblock Plus on Google Chrome:

Click the AdBlock Plus button on your browser and select Enabled on this site.

For Adblock Plus on Firefox:

Click the AdBlock Plus button on your browser and select Disable on

Then Reload the Page